ReviewJournal of applied phycology2026
Bacterial disease in seaweed aquaculture: pathogen diversity and future solutions.
Review in Journal of applied phycology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, there has been a rapid expansion in seaweed aquaculture due to the increased demand for sustainable food, pharmaceuticals, and other industrial needs. This growth has been accompanied by a rise in disease prevalence, jeopardising the economic viability of seaweed farming and the livelihoods of millions reliant on the sector. Here, through focusing on the complex interactions between seaweed hosts and their microbial communities, we review current knowledge on bacterial seaweed pathogens. We discuss the challenges associated with pathogen identification, including the constraints of traditional approaches and the complexities arising from resident commensal bacteria. We then assess the use of probiotics, selective breeding, Integrated Multi-Trophic Aquaculture (IMTA), site selection, and the priming of early life stages as emerging disease management strategies, while highlighting the need for omics-based studies to identify disease biomarkers and commercially relevant disease-resistant strains. We conclude by underlining the importance of early detection systems and improved knowledge dissemination within the sector to enable a more proactive and sustainable approach to disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.